Matching-adjusted indirect comparison of PFS and OS comparing ribociclib plus letrozole versus palbociclib plus letrozole as first-line treatment of HR+/HER2- advanced breast cancer.

Komal L JhaveriJoyce O'ShaughnessyPeter A FaschingSara M TolaneyDenise A YardleyVikash Kumar SharmaChandroday BiswasAstrid ThuerigenPurnima PathakHope S Rugo

Published in: Therapeutic advances in medical oncology (2023)

NCT01958021; https://www.clinicaltrials.gov/study/NCT01958021 (MONALEESA-2) and NCT01740427; https://clinicaltrials.gov/study/NCT01740427 (PALOMA-2).

Keyphrases

polycystic ovary syndrome
type diabetes
metabolic syndrome
adipose tissue
young adults
skeletal muscle
clinical evaluation